Live Breaking News & Updates on காங்கிரஸ் சாம்பியன்கள்
Stay updated with breaking news from காங்கிரஸ் சாம்பியன்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
email article A ban on tanning bed use by minors could prevent thousands of cases of melanoma and save millions of dollars in healthcare costs. ( Cancer) Researchers have developed the first cervical cancer model derived from human tissue, including normal cervical tissue and specimens from patients with different types of cervical cancer. ( Hubrecht Institute) Following the recommendation by an independent monitoring committee, enrollment has stopped for two clinical trials evaluating the T-cell co-stimulatory agent feladilimab in combination therapy for advanced/metastatic head and neck cancer, GlaxoSmithKline announced. The FDA authorized marketing of the first device that uses artificial intelligence for early detection of colon cancer.
Budget Passed By Congress Includes Increase In Federal Funding For Cancer Research Advocates From Pancreatic Cancer Action Network Were Instrumental in Securing Bipartisan Support For Pancreatic Cancer Research at Department of Defense News provided by Share this article Share this article LOS ANGELES, Dec. 22, 2020 /PRNewswire/ -- Congress delivered a key victory for pancreatic cancer patients and researchers today by passing its Fiscal Year (FY) 2021 budget. In response to the advocacy efforts of the Pancreatic Cancer Action Network (PanCAN), the spending package includes $15 million for the Department of Defense's (DoD) dedicated Pancreatic Cancer Research Program, more than doubling last year's inaugural investment. In addition, the package includes an overall increase in the nation's investment in biomedical research funding of $42.9 billion to the National Institutes of Health (NIH) and $6.56 billion to the National Cancer Institute (NCI).
December 14, 2020 By Marissa Chmiola, Senior Communications Lead, GHTC COVID-19 has upended our world like no disease in living memory—and underscored with devastating clarity how important smart policymaking, strong partnerships, and access to technologies are to confronting global health challenges. It’s a message that’s been central to GHTC’s advocacy over the past decade as we’ve worked to advance funding and policies to accelerate the development of new vaccines, treatments, and other tools to fight the world’s deadliest diseases, and it’s a message that especially vital today. We know we won’t successfully defeat COVID-19, or prevent future threats like it, without embracing science, partnership, and global cooperation to ensure everyone, everywhere can benefit from the fruits of research.